Norman David Eansor, Director at Marker Therapeutics, Inc. (MRKR), bought 35,712 shares at $17.50 ($500K) on 2021-03-16, disclosed to the SEC on 2023-06-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.50 | 14,285 | $250K | 50.0% |
| 2 | $17.50 | 14,285 | $250K | 50.0% |
| 3 | $0.00 | 7,142 | $0 | 0.0% |
| Total | $14.00 avg | 35,712 | $500K | 100% |
| Filing → |
| TECH | SELL | 2021-02-09 | $17.4M | — | Filing → |
| TECH | SELL | 2020-06-01 | $4.1M | — | Filing → |
| TECH | SELL | 2020-05-26 | $12.4M | — | Filing → |